The administration of an antihistomonal drug, dimetridazole, at a dose of 0-08% in feed, controlled experimental infections with Histomonas meleagridis in chickens. The treated birds developed no lesions and the duration of infection with H. meleagridis was reduced. This drug regimen, however, did not always prevent incorporation of H. meleagridis into eggs of Heterakis gallinarum; heterakid eggs pooled from medicated chickens in which H. meleagridis had never been detected transmitted the protozoan to 1 of 10 turkeys fed the eggs. Thus, therapeutic treatment of chickens with dimetridazole may reduce, but not eliminate, transmission of H. meleagridis by eggs oiH. gallinarum from medicated birds.
INTRODUCTION
Many drugs that dramatically reduce losses from histomoniasis (blackhead or infectious enterohepatitis) in turkeys and chickens do not always eliminate the causative agent, Histomonas meleagridis (Wehr, Farr & McLoughlin, 1958; Lucas, 1962; Shelton & McDougle, 1970) . This survival of H. meleagridis in a medicated bird concomitantly infected with the caecal worm Heterakis gallinarum might permit the life-cycle to continue as usual, when histomonads are ingested by heterakids and incorporated into their eggs, as was shown by Lee (1971) . In unmedicated birds with histomoniasis, caecal lesions often limit the survival and reproductive capacity of H. gallinarum (Lund & Chute, 1974) . Thus, the use of antihistomonal drugs that (1) prevent or reduce caecal lesions and (2) permit the histomonads to survive, might actually increase the numbers of Histomonasbearing heterakid eggs disseminated. We do not know whether the current widespread use of drugs to combat histomoniasis will affect, or already has affected, the levels of soil or litter contamination with Histomonas-beaxing heterakid eggs.
This study was undertaken to determine whether administration of a commonly used antihistomonal drug, dimetridazole (l,2-dimethyl-5-nitroimidazole) might alter the frequency with which H. meleagridis is transmitted by heterakids from experimentally infected chickens.
MATERIALS AND METHODS

Plan
In each of two trials, the incidence and duration of infections with H. meleagridis were determined in medicated and unmedicated birds. The ability of heterakids harvested from these birds to transmit H. meleagridis was estimated from the percentage infection in young turkeys fed the heterakids or their eggs. Because H. meleagridis can be passed from one generation of heterakids to the next, apparently without infecting the host bird (Lund & Chute, 1972a , 1973a and then can 'reappear' to produce histomoniasis in subsequent host birds (Lund & Chute, 1973a) , the transmission tests included heterakids from the medicated and unmedicated birds in which H. meleagridis was not detected.
Birds
All birds except White Leghorn chickens were taken as hatched from flocks maintained at this Institute; the White Leghorns were cockerels purchased as 1-day-old chicks. All birds were maintained in suspended, wire-floored brooders and cages to preclude extraneous infections with H. gallinarum and H. meleagridis.
New Hampshire chickens were used in Trial I. White Leghorn chickens were used in Trial II with the hope that the reproductive potential of the heterakids would be better in this breed (Chute, Lund & Wilkins, 1976) .
Medication trials
At the start of each trial the 4-to 5-week-old birds were weighed and allocated to 2 groups of 20 each of comparable weight (mean and range) according to the method of Gardiner & Wehr (1950) . Each trial included an infected, unmedicated control group and an infected, medicated group. All birds were fed standard grower mash ad libitum. From the 10th to the 16th day post-inoculation (pi.), feed for medicated birds contained dimetridazole (Emtrymix; Dr Salsbury's Laboratories, Charles City, Iowa*) at the recommended therapeutic level of 0-08 %.
Saline suspensions of heterakid eggs were prepared and given orally as described by Lund & Chute (1972 a) . These eggs were from worms harvested from naturally infected chickens and were known to carry virulent H. meleagridis. The birds in Trial I were given 133 + 14 (S.E.) embryonated eggs that had been stored at 4 °C for 6 months; the birds in Trial II were given 96 + 8 (S.E.) embryonated eggs that were freshly collected.
All birds were caged separately so that caecal droppings from individuals could be identified for use in diagnosis. The caecal droppings were observed for gross signs of histomoniasis (blood, mucus, caecal core fragments, yellow or green colour). One smear from each bird's droppings was examined for histomonads by phase-contrast microscopy (200-430 x ). The gross and microscopic examinations were made daily from days 6 to 24 p.i. and every few days thereafter. All birds were killed and examined between days 36 and 44 p.i., when their heterakids could be expected to be gravid. The procedure at necropsy included gross observation of caeca and liver for lesions of histomoniasis, phase-contrast microscopic examination of caecal contents for histomonads, and recovery of heterakids.
Female heterakids were placed in 0-5 % formalin solution in Petri dishes (separated according to source bird) and kept at room temperature for 3 weeks to allow embryonation of eggs. The embryonated eggs were then counted in 5 or more females from each bird (if fewer than 5 were present, eggs were counted in all), and the reproductive potential (number of embryonated eggs harvested/embryonated egg given) (Lund & Chute, 1974) was calculated for worms from each source (Histomonas-ipositive and -negative, medicated and unmedicated).
Tests for transmission o/H. meleagridis
Intact female heterakids, in which the embryonated eggs had been counted, were fed to 5-week-old Beltsville Small White turkeys and the resulting percentage of infection with H. meleagridis was determined at necropsy 14-18 days p.i. At least one female worm was so tested for each source bird that yielded any females with eggs that embryonated. We chose not to try to prepare pooled egg suspensions, because so few females with so few viable eggs were recovered from most sources, and we have experienced considerable losses of eggs in the pooling procedure.
The females to be tested were chosen so that the mean and range in number of embryonated eggs (in the females) fed/turkey were similar for each source (Histomonas-ipositive and -negative, medicated and unmedicated birds). In some cases, this required feeding as many as 4 females (from the same source bird)/ turkey. In Trial II the Histomonas-neg&tive birds yielded enough females to permit the addition of a test of transmission by eggs pooled from females recovered from several birds of each source.
BESULTS
Medication trials
The duration of infection with H. meleagridis in birds medicated with dimetridazole was less than that in unmedicated birds (Table 1) . With one exception, histomonads were not seen after day 14 in the droppings of the birds that were medicated on days 10-16. The exception was a White Leghorn chicken (Trial II) that was first diagnosed Histomonas-jtositive on the 9th day p.i., when it passed a caecal core fragment. This bird passed blood for the next 3 days and had no caecal discharges of any kind from days 13 to 18 p.i.; on the 19th day its droppings were normal and Histomonas-negative. However, histomonads were observed in this bird's caecal droppings on days 20 to 27 and again on day 33, and it was still infected at necropsy on day 36.
In both trials, worm recovery at necropsy was very low, except in the Histomonasnegative birds in Trial II ( Table 2 ). The survival and reproductive potential of H. gallinarum were lower in medicated birds than in the comparable unmedicated ones. 
Tests for transmission o/H. meleagridis
The origin and number of whole female heterakids fed to turkeys to test for transmission of H. meleagridis, the number of embryonated eggs in the females, and the results of the tests are shown in Table 3 . The number of turkeys that could be inoculated with females from medicated birds was limited by the scarcity of such females with viable eggs, except from Histomonas-nega,tive medicated birds in Trial II. No female heterakids tested from any medicated bird or any Historaowas-negative bird transmitted the protozoan, but it was transmitted to 12 of 18 and 5 of 9 turkeys fed 1-3 worms from Histomonas-ipositive, unmedicated birds in Trials I and II, respectively.
Pooled embryonated eggs from heterakids from Histomonas-neg&tive birds in Trial II transmitted H. meleagridis even though whole female worms from the same birds and containing about the same number of eggs did not (Table 4) ; 6 of 10 turkeys fed 98 eggs pooled from worms from unmedicated birds, and 1 of 10 fed 96 eggs pooled from worms from medicated birds, had histomonads at necropsy.
DISCUSSION
If treatment of turkeys with dimetridazole at a dose of 0-05 % is not begun by the 5th day of infection, histomonads deep in the caecal mucosa may not be exposed to the drug at a level high enough to kill them. They may then cause a relapse after therapy is stopped (Lucas, 1963) . The post-treatment infection in the previously infected chicken in Trial II may have been the result of such a relapse. Alternatively, the post-treatment infection may have been the result of a late liberation of histomonads from one or more heterakids (Lund & Chute, 1973a, 6 ). Upon withdrawal of dimetridazole (0-05%) from turkeys, the drug level in the host's tissues decreases rapidly so that almost no residues are detectable after 2 days (Condren, Davies, Deyoe, Zavala, Creger & Couch, 1963) . The lower survival and reproductive potential of Eeterakis gallinarum in medicated compared with unmedicated Histomonas-neg&tive birds may reflect a detrimental effect of dimetridazole on the nematode, either directly or indirectly, through its environment in the host. The survival and development of Histomonasnegative heterakids were consistently lower in dimetridazole-medicated birds than in unmedicated birds (A. M. Chute, unpublished data).
The failure of heterakid eggs within female worms to transmit H. meleagridis to susceptible turkeys, and the transmission of the protozoan with suspensions of eggs pooled from worms from the same source (medicated birds, Trial II), are probably results of (1) a low proportion of females harbouring infective histomonads and (2) some females harbouring more than one infective histomonad (Lund & Burtner, 1957) . The same phenomenon (i.e. suspensions of pooled eggs transmitting H. meleagridis more frequently than eggs in whole female heterakids from the same group of birds) has been noted in previous experiments (Lund & Chute, 19726; Chute et al. 1976) .
Histomonas meleagridis was transmitted by heterakid eggs from medicated chickens in which H. meleagridis had never been detected. Thus, administration of dimetridazole at therapeutic levels cannot ensure that Histomonas-be&Ting heterakid eggs are not disseminated. Eggs from medicated birds transmitted H. meleagridis less frequently than eggs from unmedicated birds in Trial II; if not due to chance, these results may indicate that use of the drug reduces the likelihood that i/isfomcraas-bearing heterakid eggs will be disseminated. However, it must be kept in mind that infections with these parasites in chickens may differ from such infections in turkeys, in which dimetridazole is more commonly used.
